does semaglutide ruin metabolism Did You Know Ozempic (semaglutide) causes significant weight loss that includes not only fat but also lean muscle mass, with some studies showing up to 39% of lost weight being muscle, leading Exploring beyond numeric weight loss:

Saxenda was the first to be approved in 2014, followed by Wegovy in 2020 and Zepbound in 2023

In an interview with BioSpace , Rosanna Ricafort, vice president and head of late development hematology and cell therapy, said the field has come a long way in terms of toxicity management guidelines and an understanding of how to manage CAR T-associated toxicities that are well characterized. March 14 Product: BeiGenes Tevimbra Indication: Esophageal squamous cell carcinoma Also coming through on a jam-packed Thursday for the FDA was a nod for BeiGenes PD-1 blocker tislelizumabwhich will carry the brand name Tevimbrain unresectable or metastatic esophageal squamous cell carcinoma

So, lets kick things off with Abby Bownas, someone that you know pretty well, Robert

2015 Sep;29(9):1679-88